Taking On Challenges And Growing? – Angiodynamic Inc (ANGO)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc..

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of Angiodynamic Inc is $246.73M. A total of 0.91 million shares were traded on the day, compared to an average of 509.42K shares.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ANGO has a high of $11.38 and a low of $5.26.

As of this writing, ANGO has an earnings estimate of -$0.14 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.18. The company reported an EPS of -$0.12 in the last quarter, which was 7.70% higher than expectations of -$0.13.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ANGO’s latest balance sheet shows that the firm has $28.82M in Cash & Short Term Investments as of fiscal 2022. There were $33.78M in debt and $74.32M in liabilities at the time. Its Book Value Per Share was $9.97, while its Total Shareholder’s Equity was $424.49M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ANGO is Buy with a score of 4.25.

Most Popular

Related Posts